Bottom line
What does FBTTX hold?
FBTTX held 129 positions as of Jul 31, 2026. Its largest holding is Abbvie Inc at 14.71% of the fund, and the top 10 positions add up to 46.9%. By asset type it is 98% stocks, 2% preferred stock, 0% bonds.
Updated Sep 23, 2026
FBTTX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Abbvie Inc | Stocks | 14.71% | $323.7M |
| 2 | Gilead Sciences Inc | Stocks | 5.70% | $125.5M |
| 3 | Spyre Therapeutics Inc | Stocks | 3.83% | $84.3M |
| 4 | Alnylam Pharmaceuticals Inc | Stocks | 3.62% | $79.6M |
| 5 | Dianthus Therapeutics Inc | Stocks | 3.55% | $78.1M |
| 6 | Cogent Biosciences Inc | Stocks | 3.25% | $71.4M |
| 7 | Oruka Therapeutics Inc | Stocks | 3.24% | $71.2M |
| 8 | Insmed Inc | Stocks | 3.05% | $67.1M |
| 9 | Revolution Medicines Inc | Stocks | 3.00% | $66.0M |
| 10 | Argenx Se ARGENX SE SPONSORED ADR |
Stocks | 3.00% | $65.9M |
| 11 | Ascendis Pharma A/s ASCENDIS PHARMA AS |
Stocks | 2.99% | $65.7M |
| 12 | Biogen Inc | Stocks | 2.71% | $59.7M |
| 13 | Mbx Biosciences Inc | Stocks | 2.45% | $53.9M |
| 14 | Amgen Inc | Stocks | 2.37% | $52.0M |
| 15 | Amylyx Pharmaceuticals Inc | Stocks | 2.25% | $49.4M |
| 16 | Vaxcyte Inc | Stocks | 1.97% | $43.3M |
| 17 | Fidelity Revere Street Trust Fidelity Securities Lending Cash Central Fund |
Cash & short-term funds | 1.96% | $43.2M |
| 18 | Moderna Inc | Stocks | 1.60% | $35.1M |
| 19 | Relay Therapeutics Inc | Stocks | 1.58% | $34.8M |
| 20 | Viridian Therapeutics Inc | Stocks | 1.53% | $33.7M |
| 21 | Natera Inc | Stocks | 1.43% | $31.4M |
| 22 | Kiniksa Pharmaceuticals International Plc | Stocks | 1.41% | $31.0M |
| 23 | Vertex Pharmaceuticals Inc | Stocks | 1.39% | $30.5M |
| 24 | Enliven Therapeutics Inc | Stocks | 1.25% | $27.5M |
| 25 | Alumis Inc | Stocks | 1.22% | $26.7M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026